Skip to main content
ACS Medicinal Chemistry Letters logoLink to ACS Medicinal Chemistry Letters
. 2017 Nov 8;8(12):1341. doi: 10.1021/acsmedchemlett.7b00457

Correction to “Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure”

Marion Lanier , Jason Pickens, Simone V Bigi, Erica L Bradshaw-Pierce, Alison Chambers, Zacharia S Cheruvallath, Derek Cole, Douglas R Dougan, Jacques Ermolieff, Tony Gibson, Petro Halkowycz, Aki Hirokawa, Anthony Ivetac, Christopher McBride, Joanne Miura, Evan Nunez, Mark Sabat, John Tyhonas, Haixia Wang, Xiaolun Wang, Steve Swann
PMCID: PMC5733265  PMID: 29259759

It has come to our attention that a significant contributor to the early design and synthesis of the chemical series disclosed in our recent ACS Medicinal Chemistry Letters publication was inadvertently left off of the list of authors. A revised list of authors can be found below, which includes the omitted co-author, Chris McBride, who is affiliated with the Department of Medicinal Chemistry, Takeda Pharmaceuticals.

Lanier, Marion*; Pickens, Jason; Bigi, Simone V.; Bradshaw-Pierce, Erica L.; Chambers, Alison; Cheruvallath, Zacharia S.; Cole, Derek; Dougan, Douglas R.; Ermolieff, Jacques; Gibson, Tony; Halkowycz, Petro; Hirokawa, Aki; Ivetac, Anthony; McBride, Christopher; Miura, Joanne; Nunez, Evan; Sabat, Mark; Tyhonas, John; Wang, Haixia; Wang, Xiaolun; and Swann, Steve.


Articles from ACS Medicinal Chemistry Letters are provided here courtesy of American Chemical Society

RESOURCES